Healthpeak Properties, Inc.

🇺🇸New York Stock Exchange
Back to all articles
Healthpeak Properties, Inc. stock analysis DOC overview
Slightly Bullish +15

Healthpeak Properties (DOC) Stock After 31% Year-To-Date Rise Is Price Getting Ahead Of Itself - simplywall.st

📈 Healthpeak Properties (DOC) shares have surged 31% year-to-date, trading at approximately $21.23.

💰 A Discounted Cash Flow model estimates an intrinsic value of $34.62, implying a 38.7% discount to current price.

📉 The stock trades at a P/E ratio of 66.0x, significantly higher than the industry average of 20.0x and peer average of 43.0x.

⚖️ Simply Wall St's proprietary Fair Ratio suggests a reasonable P/E of 28.6x, indicating a potential 24.9% premium to fair value.

🤖 Bullish narrative cites AI-driven property management and an aging population driving demand for senior housing.

⚠️ Bearish narrative highlights tenant risk in life science properties and geographic concentration as key concerns.

📊 The latest twelve-month free cash flow is reported at $1.29 billion.

🏥 DOC owns, operates, and develops high-quality real estate focused on healthcare discovery and delivery in the U.S.

Bullish Signals
  • The Discounted Cash Flow model estimates an intrinsic value of $34.62 per share, implying a 38.7% discount to the current trading price of $21.23.
  • The company reports strong recent cash generation with latest twelve-month free cash flow at $1.29 billion.
  • Bullish investor narratives highlight long-term support from senior housing exposure and outpatient medical facilities tied to an aging U.S. population.
  • Operational efficiency is expected to improve through AI-driven property management and technology upgrades aimed at enhancing tenant retention.
Risk Factors
  • The stock trades at a P/E ratio of 66.0x, which is more than three times the industry average of 20.0x for Health Care REITs.
  • Simply Wall St's proprietary Fair Ratio analysis suggests the current price represents a 24.9% premium to fair value based on a target P/E of 28.6x.
  • Bearish narratives point to significant tenant risk in life science properties, particularly from smaller biotech companies reliant on capital markets.
Full Analysis
Healthpeak Properties (DOC) shares have rallied significantly, rising 31% year-to-date and 8.5% in the last week, trading around $21.23. Simply Wall St analyzes whether this price appreciation reflects underlying fundamentals or if the stock is becoming overvalued relative to its prospects. The analysis employs two primary valuation methods yielding conflicting signals. A Discounted Cash Flow (DCF) model based on Adjusted Funds From Operations suggests an intrinsic value of $34.62, implying a 38.7% discount and indicating the stock is undervalued. Conversely, a Price-to-Earnings (P/E) analysis shows DOC trading at 66.0x earnings, which is substantially higher than the industry average of 20.0x and its peer group average of 43.0x. Simply Wall St assigns a proprietary 'Fair Ratio' P/E of 28.6x, suggesting the current price represents a 24.9% premium to fair value on this metric. The article presents two investor narratives: an upbeat view citing AI-driven efficiency and senior housing demand supporting a bullish case, and a bearish view highlighting tenant risks in life science properties and geographic concentration concerns. Ultimately, the valuation is complex with mixed signals depending on the methodology used. While cash flow models point to undervaluation, high P/E multiples and specific operational risks suggest caution. The article concludes by directing readers to community discussions for further insights on these divergent assumptions.